The recent CMS coverage determination did not make any mention of beta-amyloid PET imaging that is necessary for both diagnosing Alzheimer’s and monitoring the effectiveness of related treatments.
Richard Heiden, MD, has a compromised immune system and had asked NYC Health and Hospitals to reassign him to teleradiology duties after the COVID-19 pandemic hit.